Conditions: Ovarian Cancer
Intervention Type: Biological
Intervention Names
The following are clinical trials from the Healia Clinical Trials Information Database related to "Ovarian Cancer" that are researching the effect of "Biological" interventions organized by the name of the intervention.
- Ovarian Cancer - Biological - sargramostim (7 documents)
- Ovarian Cancer - Biological - recombinant interleukin-12 (4 documents)
- Ovarian Cancer - Biological - SS1(dsFv)-PE38 immunotoxin (2 documents)
- Ovarian Cancer - Biological - bevacizumab (2 documents)
- Ovarian Cancer - Biological - oregovomab (2 documents)
- Ovarian Cancer - Biological - polyvalent antigen-KLH conjugate vaccine (2 documents)
- Ovarian Cancer - Biological - therapeutic autologous dendritic cells (2 documents)
- Ovarian Cancer - Biological - ACA 125 (1 documents)
- Ovarian Cancer - Biological - AGS-8M4 (1 documents)
- Ovarian Cancer - Biological - AMG 655 (1 documents)
- Ovarian Cancer - Biological - Abagovomab (1 documents)
- Ovarian Cancer - Biological - Ad5CMV-p53 gene (1 documents)
- Ovarian Cancer - Biological - Aldesleukin (1 documents)
- Ovarian Cancer - Biological - AlloStim (1 documents)
- Ovarian Cancer - Biological - Allogeneic whole epithelial tumor cells, DNP-conjugated and irradiated (1 documents)
- Ovarian Cancer - Biological - CDX-1307 (1 documents)
- Ovarian Cancer - Biological - CDX1307 (1 documents)
- Ovarian Cancer - Biological - Cetuximab (1 documents)
- Ovarian Cancer - Biological - Chemotherapy Intraperitoneal and Intravenous (1 documents)
- Ovarian Cancer - Biological - DC-Ova (1 documents)
- Ovarian Cancer - Biological - DCVac-L (1 documents)
- Ovarian Cancer - Biological - DCVax-L and T Cells (1 documents)
- Ovarian Cancer - Biological - DTA-H19 (1 documents)
- Ovarian Cancer - Biological - Globo-H-GM2-sTn-TF-Tn-KLH conjugate, plus the immunological adjuvant QS-21 (1 documents)
- Ovarian Cancer - Biological - HER-2 vaccine (1 documents)
- Ovarian Cancer - Biological - LMB-9 immunotoxin (1 documents)
- Ovarian Cancer - Biological - MGAH22 (1 documents)
- Ovarian Cancer - Biological - MVF-HER-2(628-647)-CRL 1005 vaccine (1 documents)
- Ovarian Cancer - Biological - Monoclonal antibody Hu3S193 (1 documents)
- Ovarian Cancer - Biological - OCDC (1 documents)
- Ovarian Cancer - Biological - PEG-interferon alfa-2b (1 documents)
- Ovarian Cancer - Biological - Panitumumab (1 documents)
- Ovarian Cancer - Biological - Placebo (1 documents)
- Ovarian Cancer - Biological - Prevnar (1 documents)
- Ovarian Cancer - Biological - QS21 (1 documents)
- Ovarian Cancer - Biological - Ramucirumab (1 documents)
- Ovarian Cancer - Biological - The current season's trivalent killed influenza vaccine (1 documents)
- Ovarian Cancer - Biological - abagovomab (1 documents)
- Ovarian Cancer - Biological - anti-EpCAM x anti-CD3 (removab) (1 documents)
- Ovarian Cancer - Biological - bevacizumab and the polyvalent vaccine-KLH conjugate + OPT-821 (1 documents)
- Ovarian Cancer - Biological - carcinoembryonic antigen RNA-pulsed DC cancer vaccine (1 documents)
- Ovarian Cancer - Biological - denileukin diftitox (1 documents)
- Ovarian Cancer - Biological - filgrastim (1 documents)
- Ovarian Cancer - Biological - hu3S193 (1 documents)
- Ovarian Cancer - Biological - incomplete Freund's adjuvant (1 documents)
- Ovarian Cancer - Biological - ipilimumab (1 documents)
- Ovarian Cancer - Biological - peripheral blood lymphocyte therapy (1 documents)
- Ovarian Cancer - Biological - recombinant adenovirus-p53 SCH-58500 (1 documents)
- Ovarian Cancer - Biological - recombinant interferon gamma (1 documents)
- Ovarian Cancer - Biological - recombinant interleukin-11 (1 documents)
- Ovarian Cancer - Biological - therapeutic allogeneic lymphocytes (1 documents)
- Ovarian Cancer - Biological - therapeutic autologous lymphocytes (1 documents)
- Ovarian Cancer - Biological - therapeutic tumor infiltrating lymphocytes (1 documents)